Home » Topics » BioWorld Science

BioWorld Science
RSS

Mablink and Emergence enter licensing agreement for ADC targeting Nectin-4

Oct. 21, 2021

Oncodesign and TiumBio collaborate to discover and develop candidates for fibrosis

Oct. 21, 2021

HLA fine mapping identifies INPP5A as a risk gene for tuberculosis

Oct. 21, 2021

Tango Therapeutics' MTAPnull PRMT5 inhibitor TNG-908 active in multiple xenograft tumor models

Oct. 21, 2021

NPAS3 identified as a risk gene for autism spectrum disorder

Oct. 21, 2021

Mitochondrial augmentation: a promising disease-modifying strategy for mitochondrial DNA disorders

Oct. 21, 2021

Alu RNA induces retinal pigment epithelium degeneration in geographic atrophy via the inflammasome

Oct. 21, 2021

Medshine Discovery describes new compounds for cancer

Oct. 21, 2021

Dongguan Hec New Drug Research and Development synthesizes new HBV antivirals

Oct. 21, 2021

Angiex presents new TM4SF1-targeting PROTACs

Oct. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...